Sidley Austin represented BigHat Biosciences, Inc. in the transaction. BigHat Biosciences, Inc. (“BigHat”), announced a licensing collaboration with Synaffix B.V. (“Synaffix”), a Lonza company (SWX:LONN). BigHat’s...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented SanReno Therapeutics in the transaction. Novartis, a global medicines company, announced the acquisition of clinical-stage company SanReno Therapeutics (SanReno). Following the acquisition’s closure, SanReno becomes...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised Savillex Corporation on the transaction. Savillex Corporation announced that it completed its acquisition of ONFAB, from Foresight Group. The terms of the transaction were not...
You must be a Standard 1 Year member to access this content.
